Loading clinical trials...
Loading clinical trials...
Cetrorelix Pamoate (AEZS-102) in Patients With Symptomatic BPH: a Double-blind Placebo-controlled Efficacy Study
Conditions
Interventions
Cetrorelix 78+78
Cetrorelix 78 + Placebo
+1 more
Locations
54
Belarus
19th Central Regional Policlinic, Urology department
Minsk, Belarus
4th City Hospital
Minsk, Belarus
Minsk Regional Clinical Hospital, Clinic of Urology
Minsk, Belarus
University multiprofil Hospital of Active Treatment "Sveti Georgi", Urology Department
Plovdiv, Bulgaria
Aleksandrovska Hospital, Kidney Transplantation Department
Sofia, Bulgaria
Aleksandrovska Hospital, Oncourology Department
Sofia, Bulgaria
Start Date
March 1, 2008
Primary Completion Date
September 1, 2009
Completion Date
January 1, 2010
Last Updated
January 17, 2011
NCT07377929
NCT00427219
NCT02401581
NCT00382356
NCT00670306
Lead Sponsor
AEterna Zentaris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions